Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Fischer

Showing results (271-280 of 323) with videos related to

Pageof 33
Sort By:
Nature|June 3, 2026
Centromeric footprints preserve telomere integrity in ALT cancersRagini Bhargava, Megan A Mahlke, Tobias T Schmidt, et al.
The EMBO Journal|August 23, 2012
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosisKatja Höpker, Henning Hagmann, Safiya Khurshid, et al.
Nature Communications|February 25, 2021
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteomeSabine A Hartlieb, Lina Sieverling, Michal Nadler-Holly, et al.
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2026
Current treatment strategies for first relapse of high-risk neuroblastomaSveva Castelli, Franziska Schulze, Theresa M Thole-Kliesch, et al.
Nature Communications|November 17, 2020
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastomaKonstantin Helmsauer, Maria E Valieva, Salaheddine Ali, et al.
Nature Communications|July 27, 2019
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastomaMatthew Wong, Yuting Sun, Zhichao Xi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Prognostic impact of gene expression-based classification for neuroblastomaAndré Oberthuer, Barbara Hero, Frank Berthold, et al.
Nature Genetics|June 30, 2015
Mutational dynamics between primary and relapse neuroblastomasAlexander Schramm, Johannes Köster, Yassen Assenov, et al.
Cell|January 8, 2019
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsRon D Jachimowicz, Filippo Beleggia, Jörg Isensee, et al.
Pageof 33

Showing results (271-280 of 323) with videos related to

Sort By:
Pageof 33
Nature|June 3, 2026
Centromeric footprints preserve telomere integrity in ALT cancersRagini Bhargava, Megan A Mahlke, Tobias T Schmidt, et al.
The EMBO Journal|August 23, 2012
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosisKatja Höpker, Henning Hagmann, Safiya Khurshid, et al.
Nature Communications|February 25, 2021
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteomeSabine A Hartlieb, Lina Sieverling, Michal Nadler-Holly, et al.
JCI Insight|December 7, 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patientsFjoralba Zeka, Anneleen Decock, Alan Van Goethem, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2026
Current treatment strategies for first relapse of high-risk neuroblastomaSveva Castelli, Franziska Schulze, Theresa M Thole-Kliesch, et al.
Nature Communications|November 17, 2020
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastomaKonstantin Helmsauer, Maria E Valieva, Salaheddine Ali, et al.
Nature Communications|July 27, 2019
JMJD6 is a tumorigenic factor and therapeutic target in neuroblastomaMatthew Wong, Yuting Sun, Zhichao Xi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2010
Prognostic impact of gene expression-based classification for neuroblastomaAndré Oberthuer, Barbara Hero, Frank Berthold, et al.
Nature Genetics|June 30, 2015
Mutational dynamics between primary and relapse neuroblastomasAlexander Schramm, Johannes Köster, Yassen Assenov, et al.
Cell|January 8, 2019
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsRon D Jachimowicz, Filippo Beleggia, Jörg Isensee, et al.
Pageof 33